A versatile monoclonal antibody specific to human SERPINB5

Hybridoma

Volumn 31, Issue 5, 2012, Pages 333-339

  Teoh, Sonia S Y ^a   Wang, Hong ^a   Risbridger, Gail P ^a   Whisstock, James C ^a   Bird, Phillip I ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MASPIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; MICE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DENATURATION; RECOMBINANT PROTEINS; SERPINS; TRANSFECTION;

EID: 84868019657     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2012.0035     Document Type: Article

References (25)

1. Silverman GA, Whisstock JC, Askew DJ, Pak SC, Luke CJ, Cataltepe S, Irving JA, and Bird PI: Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 2004;61:301-325.
2. Silverman GA, Whisstock JC, Bottomley SP, Huntington JA, Kaiserman D, Luke CJ, Pak SC, Reichhart JM, and Bird PI: Serpins flex their muscle: I. Putting the clamps on prote-olysis in diverse biological systems. J Biol Chem 2010;285: 24299-24305.
3. Whisstock JC, Silverman GA, Bird PI, Bottomley SP, Kai-serman D, Luke CJ, Pak SC, Reichhart JM, and Huntington JA: Serpins flex their muscle: II. Structural insights into tar-get peptidase recognition, polymerization, and transport functions. J Biol Chem 2010;285:24307-24312.
4. Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, Rosado CJ, Langendorf CG, Pike RN, Bird PI, and Whisstock JC: An overview of the serpin superfamily. Genome Biol 2006;7:216.
5. Irving JA, Pike RN, Lesk AM, and Whisstock JC: Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res 2000;10:1845-1864.
6. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O'Donnell E, Salvesen GS, Travis J, and Whisstock JC: The serpins are an expanding super-family of structurally similar but functionally diverse pro-teins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001;276:33293-33296.
7. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-529.
8. Goulet B, Chan G, Chambers AF, and Lewis JD: An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis. [Special issue on asilomar chromatin.] Biochem Cell Biol 2011; 90(1):22-38.
9. Bailey CM, Khalkhali-Ellis Z, Kondo S, Margaryan NV, Seftor RE, Wheaton WW, Amir S, Pins MR, Schutte BC, and Hendrix MJ: Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J Biol Chem 2005;280:34210-34217.
10. Yin S, Li X, Meng Y, Finley RL Jr, Sakr W, Yang H, Reddy N, and Sheng S: Tumor-suppressive maspin regulates cell re-sponse to oxidative stress by direct interaction with gluta-thione S-transferase. J Biol Chem 2005;280:34985-34996.
11. Li X, Yin S, Meng Y, Sakr W, and Sheng S: Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res 2006;66:9323-9329.
12. Cella N, Contreras A, Latha K, Rosen JM, and Zhang M: Maspin is physically associated with [beta]1 integrin regu-lating cell adhesion in mammary epithelial cells. Faseb J 2006;20:1510-1512.
13. Umekita Y, Ohi Y, Sagara Y, and Yoshida H: Expression of maspin predicts poor prognosis in breast-cancer patients. J Intl Cancer 2002;100:452-455.
14. Umekita Y, and Yoshida H: Expression of maspin is up-regulated during the progression of mammary ductal car-cinoma. Histopathology 2003;42:541-545.
15. Umekita YD, Ohi YD, Souda MD, Rai YD, Sagara YD, Ta-mada SD, and Tanimoto AD: Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer. Diagn Pathol 2011;6:36.
16. Li X, Kaplun A, Lonardo F, Heath E, Sarkar FH, Irish J, Sakr W, and Sheng S: HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in pros-tate carcinoma cells. Mol Cancer Res 2011;9:733-745.
17. Debnath J, Muthuswamy SK, and Brugge JS: Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003;30:256-268.
18. Chu M, Bird CH, Teasdale M, and Bird PI: Turnover of thrombomodulin at the cell surface occurs at a similar rate to receptors that are not actively internalized. Thromb Hae-most 1998;80:119-127.
19. Bird CH, Blink EJ, Hirst CE, Buzza MS, Steele PM, Sun J, Jans DA, and Bird PI: Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol Cell Biol 2001;21:5396-5407.
20. Law RH, Irving JA, Buckle AM, Ruzyla K, Buzza M, Bash-tannyk-Puhalovich TA, Beddoe TC, Nguyen K, Worrall DM, Bottomley SP, Bird PI, Rossjohn J, and Whisstock JC: The high resolution crystal structure of the human tumor sup-pressor maspin reveals a novel conformational switch in the G-helix. J Biol Chem 2005;280:22356-22364.
21. Teoh SS, Whisstock JC, and Bird PI: Maspin (SERPINB5) is an obligate intracellular serpin. J Biol Chem 2010;285:10862-10869.
22. Teoh SS, Whisstock JC, and Bird PI: Maspin (SERPINB5) is an obligate intracellular serpin. J Biol Chem 2010;285:10862-10869.
23. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, and Sager R: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 1996;93:11669-11674.
24. Lovric E, Gatalica Z, Eyzaguirre E, and Kruslin B: Expres-sion of maspin and glutathionine-S-transferase-pi in normal human prostate and prostatic carcinomas. Appl Im-munohistochem Mol Morphol 2010;18:429-432.
25. Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Na-gasaki K, and Rudolph P: Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 2001;195:321-326.